Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 15.05.2026			% 5 Tage	Veränd. 1. Jan.
43,30 ^USD	-3,22 %		-10,46 %	-26,37 %

15.05.	Geplante Wilson-Wolf-Akquisition von Bio-Techne laut RBC von Anlegern unterschätzt	MT
12.05.	Bio-Techne: Insider-Verkauf im Wert von 320.386 Dollar laut SEC-Meldung	MT

Andere Sprachen

15.05.	Bio-Techne's Planned Wilson Wolf Acquisition Underappreciated by Investors, RBC Says
12.05.	Bio-Techne Insider Sold Shares Worth $320,386, According to a Recent SEC Filing
08.05.	Analyst recommendations: Airbnb , Citigroup , The Walt Disney Company , Block, Cloudflare...
06.05.	Bio-Techne pénalisé par le recul des financements académiques américains
06.05.	Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026
06.05.	Bio-Techne's Fiscal Q3 Adjusted Earnings, Revenue Fall
06.05.	Bio-Techne misses revenue estimates as US academic funding cuts dent demand
06.05.	Earnings Flash (TECH) Bio-Techne Corporation Reports Q3 Revenue $311.4M, vs. FactSet Est of $316.1M
06.05.	Earnings Flash (TECH) Bio-Techne Corporation Posts Q3 Adjusted EPS $0.53 per Share, vs. FactSet Est of $0.53
06.05.	Bio-Techne Declares Dividend
06.05.	Bio-Techne Releases Third Quarter Fiscal 2026 Results
06.05.	Bio-Techne Corporation announces Quarterly dividend, payable on May 29, 2026
04.05.	Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
28.04.	Cleo Diagnostics Starts Manufacturing, Development Program for Ovarian Cancer Test Kit Production; Shares Up 8%
16.04.	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
16.04.	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
16.04.	Bio-Techne Corporation Introduces Streamlined Brand Architecture With Three Portfolio Brands
14.04.	Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
26.03.	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite
25.03.	Bio-Techne Corporation Expands Comet Solution Portfolio with Addition of Spyre Focus Panels and Spyre Amplification Kits
25.03.	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
24.02.	Bio-Techne to Present at Upcoming Investor Conferences
18.02.	Cleo Diagnostics Selects Bio-Techne's Platform as Immunoassay Instrument for Ovarian Cancer Blood Test; Shares Jump 3%
16.02.	Bio-Techne's Ella Platform Achieves Ce-Ivd Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories
16.02.	Bio-Techne Corp's Ella platform receives CE-IVD marking, available for sale in EU